Schematic overview of the cellular and molecular mechanisms involved in the cancer progression, including the proposed cellular and molecular mechanisms in cancer cells trajectory. AT1: alveolar type 1 cells; AT2: alveolar type 2 cells; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IA: invasive adenocarcinoma; EMT: epithelial-mesenchymal transition

Home

Download

Statistics

Help

Contact

Center for Computational Systems Medicine
leaf

Gene summary

leaf

Malignant transformation analysis

leaf

Malignant transformation related pathway analysis

leaf

Cell-cell communication analysis

leaf

Single-cell gene regulatory network inference analysis

leaf

Somatic mutation of malignant transformation related genes

leaf

Related drugs of malignant transformation related genes

Gene: TFCP2L1

Gene summary for TFCP2L1

check button Gene summary.

Gene informationSpeciesHuman
Gene symbol

TFCP2L1

Gene ID

29842

Gene nametranscription factor CP2 like 1
Gene AliasCRTR1
Cytomap2q14.2
Gene Typeprotein-coding
GO ID

GO:0000122

UniProtAcc

Q9NZI6


Top

Malignant transformation analysis

check button Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells
check button Malignant transformation involving gene list.
Entrez IDSymbolReplicatesSpeciesOrganTissueAdj P-valueLog2FCMalignancy
29842TFCP2L1HTA11_3410_2000001011HumanColorectumAD3.09e-15-5.47e-010.0155
29842TFCP2L1HTA11_347_2000001011HumanColorectumAD3.56e-136.91e-01-0.1954
29842TFCP2L1HTA11_411_2000001011HumanColorectumSER2.87e-027.34e-01-0.2602
29842TFCP2L1HTA11_696_2000001011HumanColorectumAD1.27e-055.52e-01-0.1464
29842TFCP2L1HTA11_99999970781_79442HumanColorectumMSS4.10e-12-5.48e-010.294
29842TFCP2L1F007HumanColorectumFAP7.22e-09-6.05e-010.1176
29842TFCP2L1A002-C-010HumanColorectumFAP1.39e-14-5.26e-010.242
29842TFCP2L1A001-C-207HumanColorectumFAP3.30e-11-5.73e-010.1278
29842TFCP2L1A015-C-203HumanColorectumFAP3.53e-30-4.13e-01-0.1294
29842TFCP2L1A015-C-204HumanColorectumFAP5.27e-09-4.43e-01-0.0228
29842TFCP2L1A014-C-040HumanColorectumFAP3.93e-04-3.49e-01-0.1184
29842TFCP2L1A002-C-201HumanColorectumFAP1.24e-22-6.14e-010.0324
29842TFCP2L1A002-C-203HumanColorectumFAP9.96e-20-6.02e-010.2786
29842TFCP2L1A001-C-119HumanColorectumFAP7.86e-09-4.87e-01-0.1557
29842TFCP2L1A001-C-108HumanColorectumFAP7.30e-29-6.29e-01-0.0272
29842TFCP2L1A002-C-021HumanColorectumFAP4.12e-02-2.84e-010.1171
29842TFCP2L1A002-C-205HumanColorectumFAP8.98e-32-6.77e-01-0.1236
29842TFCP2L1A001-C-104HumanColorectumFAP4.48e-12-5.02e-010.0184
29842TFCP2L1A015-C-006HumanColorectumFAP2.31e-24-7.65e-01-0.0994
29842TFCP2L1A015-C-106HumanColorectumFAP3.38e-17-4.29e-01-0.0511
Page: 1 2 3 4 5 6 

check button Transcriptomic changes along malignancy continuum.
TissueExpression DynamicsAbbreviation
Colorectum (GSE201348)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.FAP: Familial adenomatous polyposis
CRC: Colorectal cancer
Colorectum (HTA11)The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AD: Adenomas
SER: Sessile serrated lesions
MSI-H: Microsatellite-high colorectal cancer
MSS: Microsatellite stable colorectal cancer
EsophagusThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ESCC: Esophageal squamous cell carcinoma
HGIN: High-grade intraepithelial neoplasias
LGIN: Low-grade intraepithelial neoplasias
LungThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AAH: Atypical adenomatous hyperplasia
AIS: Adenocarcinoma in situ
IAC: Invasive lung adenocarcinoma
MIA: Minimally invasive adenocarcinoma
Oral CavityThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.EOLP: Erosive Oral lichen planus
LP: leukoplakia
NEOLP: Non-erosive oral lichen planus
OSCC: Oral squamous cell carcinoma
ProstateThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.BPH: Benign Prostatic Hyperplasia
SkinThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.AK: Actinic keratosis
cSCC: Cutaneous squamous cell carcinoma
SCCIS:squamous cell carcinoma in situ
ThyroidThe image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.ATC: Anaplastic thyroid cancer
HT: Hashimoto's thyroiditis
PTC: Papillary thyroid cancer
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.

Top

Malignant transformation related pathway analysis

check buttonFind out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer
check button Figure of enriched GO biological processes.
TissueDisease StageEnriched GO biological Processes
ColorectumADGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumSERGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSSGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumMSI-HGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
ColorectumFAPGO analysis - Figure of enriched GO biological processes: Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust).
Page: 1 2 3 4 5 6 7 8 9 

check button Enriched GO biological processes.
GO IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustCount
GO:0002064ColorectumADepithelial cell development89/3918220/187232.98e-113.52e-0989
GO:0048732ColorectumADgland development149/3918436/187236.07e-116.33e-09149
GO:0007568ColorectumADaging98/3918339/187232.77e-043.39e-0398
GO:0045927ColorectumADpositive regulation of growth77/3918259/187234.82e-045.27e-0377
GO:00487321ColorectumSERgland development112/2897436/187231.75e-081.28e-06112
GO:00020641ColorectumSERepithelial cell development64/2897220/187231.96e-071.10e-0564
GO:00459271ColorectumSERpositive regulation of growth56/2897259/187235.10e-033.91e-0256
GO:00487322ColorectumMSSgland development143/3467436/187233.85e-138.01e-11143
GO:00020642ColorectumMSSepithelial cell development81/3467220/187231.02e-101.06e-0881
GO:00075681ColorectumMSSaging90/3467339/187231.51e-042.19e-0390
GO:00459272ColorectumMSSpositive regulation of growth68/3467259/187231.24e-031.19e-0268
GO:00020644ColorectumFAPepithelial cell development62/2622220/187232.74e-082.54e-0662
GO:00487324ColorectumFAPgland development103/2622436/187233.61e-083.12e-06103
GO:00459273ColorectumFAPpositive regulation of growth66/2622259/187236.11e-073.05e-0566
GO:00075682ColorectumFAPaging69/2622339/187237.66e-048.12e-0369
GO:0021700ColorectumFAPdevelopmental maturation57/2622280/187232.08e-031.72e-0257
GO:0007028ColorectumFAPcytoplasm organization5/262210/187237.32e-034.38e-025
GO:00020645ColorectumCRCepithelial cell development55/2078220/187234.63e-091.16e-0655
GO:00487325ColorectumCRCgland development88/2078436/187231.62e-082.79e-0688
GO:00459274ColorectumCRCpositive regulation of growth51/2078259/187233.23e-058.27e-0451
Page: 1 2 3 4 

check button Enriched KEGG pathways.
Pathway IDTissueDisease StageDescriptionGene RatioBg Ratiopvaluep.adjustqvalueCount
Page: 1 

Top

Cell-cell communication analysis

check buttonIdentification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states
LigandReceptorLRpairPathwayTissueDisease Stage
Page: 1 

Top

Single-cell gene regulatory network inference analysis

check buttonFind out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states
TFCell TypeTissueDisease StageTarget GeneRSSRegulon Activity
TFCP2L1ABSColorectumADHSD11B2,MUC12,HOXB13, etc.2.90e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1IMENTColorectumADHSD11B2,MUC12,HOXB13, etc.1.46e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1IMENTColorectumCRCSCNN1B,FKBP5,ATP1A1, etc.5.44e-02The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1ABSColorectumFAPSCNN1B,FKBP5,ATP1A1, etc.2.36e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1IMENTColorectumFAPSCNN1B,FKBP5,ATP1A1, etc.1.48e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1ABSColorectumMSSHSD11B2,MUC12,HOXB13, etc.1.02e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1ABSColorectumSERHSD11B2,MUC12,HOXB13, etc.2.79e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1IMENTColorectumSERHSD11B2,MUC12,HOXB13, etc.1.81e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1CD8TEXPColorectumFAPKIAA1671,IL18BP,PDE9A, etc.8.33e-02The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
TFCP2L1CD8TEXPColorectumHealthyKIAA1671,IL18BP,PDE9A, etc.1.37e-01The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression.
Page: 1 2 3 

Top

Somatic mutation of malignant transformation related genes

check buttonAnnotation of somatic variants for genes involved in malignant transformation
Hugo SymbolVariant ClassVariant ClassificationdbSNP RSHGVScHGVSpHGVSp ShortSWISSPROTBIOTYPESIFTPolyPhenTumor Sample BarcodeTissueHistologySexAgeStageTherapy TypesDrugsOutcome
TFCP2L1SNVMissense_Mutationrs376318030c.692G>Ap.Arg231Glnp.R231QQ9NZI6protein_codingdeleterious(0)probably_damaging(0.995)TCGA-A2-A04Q-01Breastbreast invasive carcinomaFemale<65I/IIChemotherapyadriamycinSD
TFCP2L1SNVMissense_Mutationnovelc.974N>Gp.Gln325Argp.Q325RQ9NZI6protein_codingtolerated(0.06)benign(0.01)TCGA-AC-A5EH-01Breastbreast invasive carcinomaFemale>=65I/IIUnknownUnknownSD
TFCP2L1SNVMissense_Mutationc.1396N>Cp.Glu466Glnp.E466QQ9NZI6protein_codingtolerated(0.21)benign(0.024)TCGA-BH-A18V-01Breastbreast invasive carcinomaFemale<65I/IIUnknownUnknownSD
TFCP2L1deletionFrame_Shift_Delnovelc.736delCp.Gln246SerfsTer22p.Q246Sfs*22Q9NZI6protein_codingTCGA-D8-A27V-01Breastbreast invasive carcinomaFemale<65I/IIHormone TherapytamoxiphenSD
TFCP2L1deletionFrame_Shift_Delnovelc.1259delNp.Asn420ThrfsTer25p.N420Tfs*25Q9NZI6protein_codingTCGA-EW-A2FV-01Breastbreast invasive carcinomaFemale<65III/IVChemotherapydocetaxelSD
TFCP2L1SNVMissense_Mutationrs779989444c.361C>Tp.Arg121Trpp.R121WQ9NZI6protein_codingdeleterious(0)probably_damaging(0.985)TCGA-2W-A8YY-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinCR
TFCP2L1SNVMissense_Mutationc.920N>Tp.Pro307Leup.P307LQ9NZI6protein_codingdeleterious(0.01)probably_damaging(0.951)TCGA-DS-A0VN-01Cervixcervical & endocervical cancerFemale<65I/IIChemotherapycisplatinSD
TFCP2L1SNVMissense_Mutationrs765369796c.670N>Ap.Asp224Asnp.D224NQ9NZI6protein_codingdeleterious(0)probably_damaging(0.991)TCGA-D5-6540-01Colorectumcolon adenocarcinomaMale>=65I/IIUnknownUnknownSD
TFCP2L1SNVMissense_Mutationrs768235839c.1334G>Ap.Ser445Asnp.S445NQ9NZI6protein_codingdeleterious(0.05)benign(0.079)TCGA-AG-A036-01Colorectumrectum adenocarcinomaMale>=65III/IVChemotherapy5-fluorouracilCR
TFCP2L1deletionFrame_Shift_Delc.1279delCp.Gln427SerfsTer18p.Q427Sfs*18Q9NZI6protein_codingTCGA-CK-5916-01Colorectumcolon adenocarcinomaFemale>=65I/IIUnknownUnknownPD
Page: 1 2 3 4 5 

Top

Related drugs of malignant transformation related genes

check buttonIdentification of chemicals and drugs interact with genes involved in malignant transfromation
(DGIdb 4.0)
Entrez IDSymbolCategoryInteraction TypesDrug Claim NameDrug NamePMIDs
Page: 1